Search Results - "SCHIOPU, Elena"
-
1
The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases
Published in Clinical immunology (Orlando, Fla.) (01-02-2017)“…Abstract Multiple sclerosis (MS) is a prototype autoimmune disease of the central nervous system (CNS). Currently, there is no drug that provides a cure for…”
Get full text
Journal Article -
2
Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
Published in Diabetes care (01-05-2022)“…Type 1 diabetes mellitus (T1DM) is a rare, irreversible immune-related adverse event reported in patients receiving treatment with immune checkpoint inhibitors…”
Get full text
Journal Article -
3
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-01-2020)“…Objective T cells play a key role in the pathogenesis of early systemic sclerosis. This study was undertaken to assess the safety and efficacy of abatacept in…”
Get full text
Journal Article -
4
Photoacoustic tomography for human musculoskeletal imaging and inflammatory arthritis detection
Published in Photoacoustics (Munich) (01-12-2018)“…With the capability of assessing high resolution optical contrast in soft tissues, photoacoustic imaging (PAI) can offer valuable structural and functional…”
Get full text
Journal Article -
5
Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)
Published in Chest (01-10-2018)“…Pulmonary arterial hypertension (PAH) is a leading cause of death in patients with systemic sclerosis (SSc). The purpose of this study was to assess long-term…”
Get full text
Journal Article -
6
Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2016)“…Objective Vascular dysfunction represents a disease‐initiating event in systemic sclerosis (SSc; scleroderma). Results of recent studies suggest that…”
Get full text
Journal Article -
7
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-02-2016)“…Objective Early diffuse cutaneous systemic sclerosis (dcSSc) is characterized by rapid changes in the skin and internal organs. The objective of this study was…”
Get full text
Journal Article -
8
Photoacoustic Imaging of COVID-19 Vaccine Site Inflammation of Autoimmune Disease Patients
Published in Sensors (Basel, Switzerland) (01-03-2023)“…Based on the observations made in rheumatology clinics, autoimmune disease (AD) patients on immunosuppressive (IS) medications have variable vaccine site…”
Get full text
Journal Article -
9
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Published in PloS one (09-11-2017)“…There are no effective treatments or validated clinical response markers in systemic sclerosis (SSc). We assessed imaging biomarkers and performed gene…”
Get full text
Journal Article -
10
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
Published in Arthritis research & therapy (17-01-2024)“…Dermatomyositis is an idiopathic inflammatory myopathy characterised by rashes and progressive muscle weakness. The recent ProDERM (Progress in…”
Get full text
Journal Article -
11
Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
Published in Arthritis Care & Research (01-03-2014)“…Objective To assess cumulative survival rates and identify independent predictors of mortality in patients with incident systemic sclerosis (SSc)–associated…”
Get full text
Book Review Journal Article -
12
Survival in Systemic Sclerosis With Pulmonary Arterial Hypertension Has Not Improved in the Modern Era
Published in Chest (01-10-2013)“…Background The impact of modern therapy on survival in pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc) is not clear. We sought…”
Get full text
Journal Article -
13
Ipilimumab induced digital vasculitis
Published in Journal for immunotherapy of cancer (12-02-2018)“…Immune check point inhibitors (ICIs) have emerged as a new therapeutic paradigm for a variety of malignancies including metastatic melanoma. As the use of ICIs…”
Get full text
Journal Article -
14
Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): Baseline Characteristics and Description of Study Population
Published in Journal of rheumatology (01-10-2011)“…Pulmonary arterial hypertension (PAH) increases mortality in systemic sclerosis (SSc). The multicenter PHAROS registry (Pulmonary Hypertension Assessment and…”
Get full text
Journal Article -
15
Utility of Coronary Calcium Scoring (CCS) in Connective Tissue Disorders (CTDs) for the Evaluation of Subclinical Coronary Atherosclerosis – A Systematic Review
Published in ACR open rheumatology (01-02-2020)“…Objective To assess the current state of knowledge for the utility of coronary calcium scoring (CCS) in connective tissue disorders (CTDs) as it relates to the…”
Get full text
Journal Article -
16
Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study
Published in Journal of rheumatology (01-01-2014)“…To estimate the prevalence, determine the subgroups at risk, and the outcomes of patients with systemic sclerosis (SSc) and gastric antral vascular ectasia…”
Get full text
Journal Article -
17
Activation of the Thromboxane A2 Receptor by 8-Isoprostane Inhibits the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in Scleroderma
Published in Journal of investigative dermatology (01-12-2015)“…The pathogenesis of scleroderma (SSc) includes components of autoimmunity, vascular dysfunction, and accumulation of extracellular matrix. 8-isoprostane, an…”
Get full text
Journal Article -
18
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies
Published in Rheumatic & musculoskeletal diseases open (01-03-2022)“…ObjectivesTo evaluate the efficacy through 52 weeks of guselkumab, an interleukin 23-p19 subunit inhibitor, in subgroups of pooled psoriatic arthritis (PsA)…”
Get full text
Journal Article -
19
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study
Published in Seminars in arthritis and rheumatism (01-08-2014)“…Abstract Objectives PHAROS registry is a prospective longitudinal cohort study to understand the natural history of pulmonary hypertension (PH) in systemic…”
Get full text
Journal Article -
20
Relapsing Polychondritis following Treatment with Secukinumab for Ankylosing Spondylitis: Case Report and Review of the Literature
Published in Case reports in rheumatology (2018)“…Relapsing polychondritis (RP) is an autoimmune disorder that often occurs concomitantly with other autoimmune diseases, though RP has been infrequently…”
Get full text
Journal Article